Download PDF
1 / Pages

Other users also viewed these articles

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease Juan Pablo Arab; Melisa Dirchwolf; Mário Reis Álvares-da-Silva; Francisco Barrera; Carlos Benítez; Marlene Castellanos-Fernandez; Graciela Castro-Narro; Norberto Chavez-Tapia; Daniela Chiodi; Helma Cotrim; Kenneth Cusi; Claudia Pinto Marques Souza de Oliveira; Javier Díaz; Eduardo Fassio; Solange Gerona; Marcos Girala; Nelia Hernandez; Sebastián Marciano; Walter Masson; Nahum Méndez-Sánchez; Nathalie Leite; Adelina Lozano; Martín Padilla; Arturo Panduro; Raymundo Paraná; Edison Parise; Marlene Perez; Jaime Poniachik; Juan Carlos Restrepo; Andrés Ruf; Marcelo Silva; Martín Tagle; Monica Tapias; Kenia Torres; Eduardo Vilar-Gomez; José Eduardo Costa Gil; Adrian Gadano; Marco Arrese;
Ann Hepatol. 2020;19:674-90
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies Umar Hayat; Ali A. Siddiqui; Hayrettin Okut; Saba Afroz; Syed Tasleem; Ahmed Haris;
10.1016/j.aohep.2020.08.071
Ethanol with thioacetamide murine model of alcoholic liver disease identifies hepatic pathways as targets for the human disease Ashi Mittal; Nishu Choudhary; Sudrishti Chaudhary; Anupama Kumari; Archana Rastogi; Guresh Kumar; Jaswinder Singh Maras; Shiv K Sarin; Shvetank Sharma;
10.1016/j.aohep.2024.101565